http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013295059-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33883bf71d5635b4478133c06607e0cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5cf811e10ad9068ddf72c04b69c8ba8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-82 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0087 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
| filingDate | 2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b2130fbd4ea49ce8f6800a00ba8a265 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14270fb43aae923f61f6f665dc9afe54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c6d320a2e025443eefb4e114e0f927 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d8cb8ab7bce0e531ae828edbb55320d |
| publicationDate | 2013-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2013295059-A1 |
| titleOfInvention | Rhodamine derivatives for photodynamic diagnosis and treatment |
| abstract | Compositions and methods for reducing or preventing graft-versus-host disease associated with allogeneic stem cell transplantation are described. A method includes harvesting hematopoietic cells from a patient with an immunologic disorder and harvesting hematopoietic cells from a donor. The harvested hemaptopoietic cells from the patient and the donor are mixed ex vivo for a period of time sufficient to activate lymphocytes within the hematopoietic cells harvested from the donor such that an immune reaction occurs and an activated portion and an unactivated portion is produced. A rhodamine B derivative is then added to the mixture of cells and the mixture is irradiated at a suitable wavelength and intensity for the selective destruction and/or inactivation of the activated portion without substantially affecting the unactivated portion or causing systemic toxicity in said patient. The irradiated cells are then infused into the patient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015187940-A1 |
| priorityDate | 1999-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 206.